Schwartz Jeffrey Lawrence's Form 4 filing
SpringWorks Therapeutics, Inc.SWTX · filed Aug 12, 2021
- Accession no.
- 0000899243-21-032893
- Filed
- Aug 12, 2021, 8:38 PM ET
- Trade date
- Aug 10, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction. Open-market sales total $70.3M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Schwartz Jeffrey LawrenceCIK 0001702957 | Director, 10% Owner |
| Koppel AdamCIK 0001578965 | 10% Owner |
| Bain Capital Life Sciences Investors, LLCCIK 0001703031 | 10% Owner |
| BC SW, LPCIK 0001786351 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 10, 2021 | Common Stock | SSaleDisposed | −1,000,000 | $70.25 | −$70,250,000 | 4,831,307 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.